"Hordes of cash by Big Pharma and the larger bioetch companies have accumulated, and now that health ca...
"Hordes of cash by Big Pharma and the larger bioetch companies have accumulated, and now that health care reform is behind us, they've got a bit more confidence and they want to fill in their pipeline and be in control of the FDA process," says Joel Papernik, a partner of Mintz Levin in The Deal's video. "They have a lot of motivation to buy right now," including the expiration of many patents, he says. The interview with Papernik is part of our special series on Faces of the Middle Market. Read the full story in The Deal magazine, watch the videos, listen to the podcasts and read the white papers. Watch the interview with Papernik below or download it on iTunes. . -- Mary Kathleen Flynn
Executive Producer: Tom Groppe
Producer: Maria Woehr
Writers: Nathaniel Baker, Mary Kathleen Flynn and Chris Nolter
Camera: George White
Editing: George White and Vipal Monga
Sound: Maria Woehr
Art and Photos: Chris Kwieraga, Linda Peng and Neil Buchalter
Copyeditor: Alexander Dering
Garrett Baker on cable M&A
Updata Advisors' Ira Cohen on tech M&A
Jordan Edmiston's Scott Peters on media M&A
Manatt Phelps' Jay Rand on tech M&A
If you have questions, suggestions or would like to appear on Deal Video please contact Maria Woehr at mwoehrthedeal.com.